CJC-1295 with DAC 5mg

CJC-1295 with DAC 5mg – Research Overview

CJC-1295 with DAC 5mg is a synthetic analog of growth hormone–releasing hormone (GHRH) engineered for extended receptor interaction in laboratory research environments. The inclusion of DAC (Drug Affinity Complex) technology allows CJC-1295 with DAC 5mg to exhibit prolonged stability and receptor engagement in controlled in vitro and preclinical research models.

CJC-1295 with DAC 5mg is widely referenced in experimental studies examining somatotropic axis regulation, GHRH receptor pharmacology, and intracellular signaling cascades associated with growth hormone pathway activation.

Supplied in lyophilized form to preserve structural integrity and enhance storage stability, CJC-1295 with DAC 5mg is intended exclusively for laboratory research and analytical investigation.

Molecular Characteristics of CJC-1295 with DAC 5mg

CJC-1295 is a modified 29–amino acid peptide structurally derived from endogenous GHRH. The addition of the Drug Affinity Complex (DAC) extends the peptide’s half-life in research systems by facilitating reversible binding to albumin, thereby increasing systemic stability in experimental models.

In laboratory environments, CJC-1295 with DAC 5mg is studied for:

• GHRH receptor activation

• Adenylate cyclase stimulation

• Cyclic AMP (cAMP) production

• Protein kinase A (PKA) pathway engagement

• Somatotropic axis modeling

• Gene transcription modulation associated with endocrine signaling

The DAC modification distinguishes this formulation from CJC-1295 no DAC (Mod GRF 1-29), which is shorter-acting in research models.

Mechanism of Action (Research Context)

In controlled laboratory systems, CJC-1295 with DAC 5mg binds selectively to the growth hormone–releasing hormone receptor (GHRH-R) located on anterior pituitary somatotroph cells.

Upon receptor activation, intracellular signaling pathways may include:

• Activation of adenylate cyclase

• Increased cyclic AMP (cAMP) levels

• Protein kinase A (PKA) activation

• Modulation of transcription factors

• Regulation of somatotropic signaling cascades

The DAC component extends receptor interaction duration in experimental models, enabling researchers to examine sustained receptor activation and downstream intracellular effects.

This extended-activity profile allows comparison between pulsatile receptor activation (no DAC versions) and prolonged receptor stimulation (with DAC) under structured laboratory conditions.

Research Applications

CJC-1295 with DAC 5mg is frequently referenced in laboratory investigations involving:

1. Growth hormone–releasing hormone receptor studies

2. Somatotropic pathway modeling

3. Intracellular second messenger pathway analysis

4. Endocrine cascade research

5. Receptor pharmacodynamics evaluation

6. Long-acting peptide stability studies

In molecular biology and endocrine research laboratories, CJC-1295 with DAC 5mg provides a framework for analyzing sustained receptor activation dynamics and prolonged signaling cascade engagement.

Researchers studying GHRH receptor biology often consult peer-reviewed databases such as the National Center for Biotechnology Information (NCBI) for foundational literature on somatotropic regulation.

Comparison: With DAC vs No DAC

A key distinction in research models is the presence or absence of the Drug Affinity Complex.

CJC-1295 with DAC 5mg:

• Extended receptor interaction

• Prolonged signaling cascade activation

• Suitable for sustained stimulation models

CJC-1295 no DAC (Mod GRF 1-29):

• Shorter receptor engagement

• Pulsatile activation modeling

• Suitable for transient signaling research

This difference enables comparative analysis of endocrine pathway dynamics in structured experimental settings.

Stability and Laboratory Handling

CJC-1295 with DAC 5mg is supplied as a lyophilized white powder to maintain peptide stability and reduce hydrolytic degradation before reconstitution.

For laboratory research use:

• Store under recommended refrigerated conditions

• Avoid repeated freeze–thaw cycles

• Reconstitute with sterile laboratory-grade solvent

• Follow institutional peptide handling protocols

Lyophilization supports long-term stability and consistent peptide performance across experimental applications.

Proper storage and preparation are essential to maintain molecular integrity and ensure reproducible research outcomes.

Product Specifications

• Compound: CJC-1295 with DAC

• Classification: Long-Acting GHRH Analog

• Structure: Modified 29–amino acid peptide with Drug Affinity Complex

• Strength: 5mg

• Form: Lyophilized sterile powder

• Appearance: White to off-white solid

• Storage: Refrigerated conditions recommended

• Intended Use: Laboratory research only

CJC-1295 with DAC 5mg is formulated exclusively for scientific research and professional laboratory use.

Analytical Verification and Quality Standards

Each batch of CJC-1295 with DAC 5mg undergoes analytical verification to confirm peptide identity and purity using validated laboratory methodologies. These may include:

• High-performance liquid chromatography (HPLC)

• Mass spectrometry analysis

• Structural sequence confirmation

• Batch-to-batch consistency validation

Lot identification numbers are assigned to support traceability and documentation within structured research protocols.

Quality control measures are implemented to maintain consistent production standards.

Broader Scientific Context

CJC-1295 with DAC 5mg is widely referenced in laboratory research exploring somatotropic signaling and receptor-mediated endocrine regulation. The extended receptor engagement profile provided by the DAC modification offers a structured model for analyzing sustained intracellular signaling cascades.

Such research contributes to a broader understanding of peptide pharmacology and receptor dynamics within endocrine pathway studies.

Compliance Notice

CJC-1295 with DAC 5mg is intended strictly for laboratory research use.

This product is not approved for human consumption, therapeutic application, or clinical use. CJC-1295 with DAC 5mg is sold exclusively for in vitro research, analytical testing, and scientific investigation by qualified professionals.